Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
The Indian smartwatch market has never been more exciting or more competitive. Very often, we get new options, yet one device ...
LED back, Snapdragon power, big battery and bold design meet real-world performance. A flashy phone that surprisingly gets ...
Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.
Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, ...
The Oura Ring and Whoop wristband are both screenless health-tracking devices that offer wellness insights while keeping ...
Apple can continue selling redesigned Apple Watches with a blood oxygen feature after the International Trade Commission ...
Here's the latest update in the Masimo vs Apple case ...
The handset maker’s latest device, the Infinix Note 60 Pro, combines a big battery, a smooth display, and AI-powered features ...
India’s mid-range smartphone market is currently the industry’s most intense battleground. To capture the attention of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results